Font Size: a A A
Keyword [relapsed refractory]
Result: 1 - 20 | Page: 1 of 3
1. Two Focuses Of Allogeneic Hematopoietic Stem Cell Transplantation
2. Expression Of P-glycoprotein And Bcl-2 Protein In Leukemia: Associations And Significance
3. Clinical Study Of New Therapy For Relapsed/refractory Multiple Myeloma
4. Clinical Analysis Of FLAG Regimen In The Treatment Of Relapsed/refractory Acute Myeloid Leukemia
5. The Study Of Bortezomib Alone Or In Combination With Harringtonine Or Arsenic Trioxide On Proliferation And Apoptosis Of The Multidrug Resistant Acute Myeloid Leukemia Cells
6. Salvaged Allogeneic Hematopoietic Stem Cell Transplantation For Patients With Recurrent Hematologic Malignancies After First Stem Cell Transplantation
7. 2 Cases Of Relapsed/Refractory Hematologic Malignancies Treated By Chemotherapy Combination With Modified Donor Lymphocyte Infusion And The Literature Review
8. The Separation Of Specific Serum Protein Biomarker In Patients With Relapse/refractory Diffuse Large B Cell Lymphoma And The Study Of Its Clinical Value
9. The Efficacy And Safety Of Hyper-CVAD/MA Regimen In The Treatment Of Relapsed Or Refractory Diffuse Large B-cell Lymphoma
10. The Present And Updates In Treatment Of Adult Patients With Relapsed Or Refractory Acute Myeloid Leukemia
11. Clinicalanalysis Of Allo-HSCT For Adult Relapsed / Refractoryacute Myeloid Leukemia
12. Proteomic Analysis Of Relapsed/Refractory NK/T Cell Lymphoma And Functional Study Of Key Proteins
13. Role Of CCL2 And VEGF Secreted By Bone Marrow Stromal Cells On Acute Myeloid Leukemia
14. The Study On Efficacy And Correlative Factors Of CD19 Chimeric Antigen Receptor T Cells Therapy In Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
15. Possible Factors On Efficacy And Safety Of CAR-T Therapy In Relapsed Or Refractory Lymphomas
16. Predictive Value Of Serum Amyloid A And Misfolded Transthyretin In Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
17. Treatment Of Relapsed/Refractory Ph-acute Lymphocytic Leukemia By VP16?Ifosfamide And Mitoxantrone Regimen
18. Clinical Characteristics And Prognosis Analysis Of 189 Non-hodgkin's Lymphoma In Childhood
19. The Clinical Research Of Low-dose Lenalidomine Plus Rituximab For Naive Elderly Or Relapsed/refractory B-non-Hodgkin's Lymphoma
20. Clinical Characteristics And Prognosis Prediction Model For Patients With Relapsed/refractory Diffuse Large B-cell Lymphoma
  <<First  <Prev  Next>  Last>>  Jump to